Search

Displaying results 9411 - 9420 of 10000 in total
  1. Drug

    LV305

    go.drugbank.com/drugs/DB17288
    Investigational

    LV305 is an active component of CMB305 along with [G305].[L47346]

  2. Drug

    QR-313

    go.drugbank.com/drugs/DB17867
    Investigational

    QR-313 is an antisense oligonucleotide targeting exon 73. It is being investigated for the treatment of dystrophic epidermolysis bullosa.[A259867]

  3. Drug

    Olpasiran

    go.drugbank.com/drugs/DB19001
    Investigational

    Olpasiran is under investigation in clinical trial NCT05581303 (Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (Ocean(a)) - Outcomes Trial).

  4. Drug

    Streptodornase

    go.drugbank.com/drugs/DB19273
    Investigational

    Streptodornase is under investigation in clinical trial NCT04252963 (Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(streptokinase • Streptodornase)).

  5. Drug

    Procizumab

    go.drugbank.com/drugs/DB23041
    Investigational

    Procizumab is under investigation in clinical trial NCT06331884 (Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics/-Dynamics of AK1967 (Procizumab)).

  6. Drug

    NBQ72S

    go.drugbank.com/drugs/DB26052
    Investigational

    NBQ72S is under investigation in clinical trial NCT06810804 (A Phase IIa Study to Evaluate NBQ72S).

  7. Drug

    Gemcabene

    go.drugbank.com/drugs/DB05123
    Investigational

    Gemcabene is a new drug that lowers low-density lipoprotein cholesterol (LDL-C), decreases triglycerides, and raises high-density lipoprotein cholesterol (HDL-C).

  8. Drug

    Bedoradrine

    go.drugbank.com/drugs/DB05590
    Investigational

  9. Drug

    PRX-03140

    go.drugbank.com/drugs/DB05596
    Investigational

  10. Drug

    OP-145

    go.drugbank.com/drugs/DB05672
    Experimental

    OP-145 is a synthetic antimicrobial peptide developed from human cathelicidin LL-37.